EU backs J&J hepatitis C pill plus new drugs from Lilly, Takeda

[riky]

EU backs J&J hepatitis C pill plus new drugs from Lilly, Takeda

European regulators have recommended approval of a new pill for hepatitis C from Johnson & Johnson, underscoring the rapid development of oral treatment options for the liver-destroying disease. The green light from the European Medicines Agency (EMA) for J&J's Olysio, also known as simeprevir, follows U.S. approval for the treatment in November. The drug, which was developed in collaboration with Sweden's Medivir, is one of several that is vying for a share of a major new market in treatments for hepatitis C. The new wave of pills cut the need for debilitating interferon injections. The European Medicines Agency (EMA) also said on Friday it had backed new drugs from Eli Lilly, Takeda and Endocyte.

Source: You are not allowed to view links. Register or Login